Decreased expressions of toll-Like receptor 9 and its signaling molecules in chronic hepatitis B virus-Infected patients

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 11, 2013, Pages 1674-1679

  Sajadi Dr , Seyyed Mohammad A ^a   Mirzaei Dr , Vahid ^a   Hassanshahi Dr , Gholamhossein ^b   Khorramdelazad Dr , Hossein ^b   Daredor Dr , Hassan Y ^c   Hosseini Dr , Seyyed Mohammad H ^d   Moogooi Dr , Mojgan ^e   Ravary Dr , Ali ^f   Arababadi Dr , Mohammad K ^g   Kennedy Dr , Derek ^h  

^a Departments of Internal Medicine   (United States)

^b Faculty of Medicine   (United States)

^c Departments of Biochemistry   (United States)

^d RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Departments of Immunology   (United States)

^f Knowledge Utilization Studies Program   (United States)

^g Immunology of Infectious Diseases Research Center   (United States)

^h GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, HUMAN; MESSENGER RNA; MYD88 PROTEIN, HUMAN; MYELOID DIFFERENTIATION FACTOR 88; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VIRUS DNA;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALE; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; DNA, VIRAL; DOWN-REGULATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MIDDLE AGED; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 9; VIRAL LOAD;

EID: 84887830171     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0415-OA     Document Type: Article

References (25)

1. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-406
2. Assar A, Arababadi MK, Mohit M, et al. T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran. Clin Lab. 2012;58(1-2):53-60
3. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, et al. Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol. 2005;75(2):227-234
4. Eftekhari Y, Arababadi MK, Hakimi H, Zarandi ER. Common HBV genotype in southeastern Iranian patients. Arch Iran Med. 2010;13(2):147-149
5. Chan HL, Jia J. Chronic hepatitis B in Asia-new insights from the past decade. J Gastroenterol Hepatol. 2011;26(suppl 1):131-137
6. Mendy ME, Welzel T, Lesi OA, et al. Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in the Gambia, West Africa. J Viral Hepat. 2009;17(2):115-122
7. Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg. 2011;74(1):4-8
8. Ahmadabadi BN, Hassanshahi G, Arababadi MK, Leanza C, Kennedy D. The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection. Inflammation. 2012;35(3):818-821
9. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Rezvani ME. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. J Gastroenterol Hepatol. 2009;25(1): 90-93
10. Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett. 2006;239(1): 10-20
11. Nguyen-Pham TN, Lim MS, Nguyen TA, et al. Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists. Cell Mol Immunol. 2011;8(4):341-347
12. Bae YS, Lee JH, Choi SH, et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res. 2009;104(2):210-218
13. Hirayama T, Tamaki Y, Takakubo Y, et al. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharidecoated titanium particles. J Orthop Res. 2011;29(7):984-992
14. Imani Fooladi AA, Mousavi SF, Seghatoleslami S, Yazdani S, Nourani MR. Toll-like receptors: role of inflammation and commensal bacteria. Inflamm Allergy Drug Targets. 2011;10(3):198-207
15. Jia N, Xie Q, Lin L, et al. Common variants of the TLR9 gene influence the clinical course of HBV infection. Mol Med Report. 2009;2(2):277-281
16. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2007; 14: 14.12.1-14.12.13
17. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79(11):7269-7272
18. Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, CMA. The guide of prevention and treatment in viral hepatitis. Chin J Hepatol. 2008: 324-9
19. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18(18): 2195-2224
20. Xu N, Yao HP, Sun Z, Chen Z. Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacol Sin. 2008;29(2):239-244
21. Zhou J, Huang Y, Tian D, Xu D, Chen M, Wu H. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J Huazhong Univ Sci Technolog Med Sci. 2009; 29(3):313-317
22. Xie Q, Shen HC, Jia NN, et al. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect. 2009;11(4):515-523
23. Vincent IE, Zannetti C, Lucifora J, et al. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One. 2011;6(10): e26315
24. Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D. Impaired Tolllike receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends Immunol. 2010;31(10):391-397
25. Xu Y, Hu Y, Shi B, et al. HBsAg inhibits TLR9-mediated activation and IFNalpha production in plasmacytoid dendritic cells. Mol Immunol. 2009;46(13): 2640-2646